SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-292939
Filing Date
2022-11-28
Accepted
2022-11-28 08:08:14
Documents
14
Period of Report
2022-11-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d405812d8k.htm   iXBRL 8-K 35169
2 EX-99.1 d405812dex991.htm EX-99.1 13955
6 GRAPHIC g405812new.jpg GRAPHIC 10172
  Complete submission text file 0001193125-22-292939.txt   189961

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA selb-20221122.xsd EX-101.SCH 2861
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE selb-20221122_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE selb-20221122_pre.xml EX-101.PRE 10820
8 EXTRACTED XBRL INSTANCE DOCUMENT d405812d8k_htm.xml XML 3266
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 221421133
SIC: 2834 Pharmaceutical Preparations